Breaking News, Collaborations & Alliances

Innovassynth, Actylis Partner on Nucleic Acid Supply Chain Vulnerabilities

Actylis offers complementary products to the Innovassynth range through its recently acquired GMP manufacturing capabilities in Europe and the U.S.

Innovassynth and Actylis will collaborate to allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials. Innovassynth is a custom development and manufacturing organization (CDMO) and a partner to pharma and drug discovery, life sciences, diagnostics, and material science companies worldwide. Innovassynth has technological expertise and extensive experience in the field of chemistry, and they provide services from development to commercialization of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters